Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


27.11.2017

4 Ann Intern Med
1 Arch Virol
2 Gastroenterology
4 Hepatology
2 J Hepatol
9 J Infect Dis
2 J Viral Hepat
3 J Virol
2 Lancet Infect Dis
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. ABARA WE, Qaseem A, Schillie S, McMahon BJ, et al
    Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-1106.
    PubMed     Text format     Abstract available


  2. Hepatitis B Vaccination, Screening, and Linkage to Care.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/P17-9048.
    PubMed     Text format    

  3. BERSOFF-MATCHA SJ, Cao K, Jason M, Jones SC, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:760.
    PubMed     Text format    

  4. MAHALE P, Glenn JS, O'Brien TR
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:759-760.
    PubMed     Text format    


    Arch Virol

  5. SILVA FQ, Santos FJA, Andrade AP, Pacheco SDB, et al
    Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.
    Arch Virol. 2017 Nov 21. doi: 10.1007/s00705-017-3656.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. SHERMAN KE, Shah VH
    Viral Hepatitis: Knowledge and Treatments for HBV/HCV and Associated Transplantation and Neoplasia.
    Gastroenterology. 2017 Nov 14. pii: S0016-5085(17)36348.
    PubMed     Text format    

  7. TREPO E, Goossens N, Fujiwara N, Song WM, et al
    Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2017 Nov 17. pii: S0016-5085(17)36367.
    PubMed     Text format     Abstract available


    Hepatology

  8. PARK H, O'Brien TR, Rehermann B
    The role of genetics in hepatic fibrosis amongst HCV patients.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29659.
    PubMed     Text format    

  9. KALAL C, Shukla A, Mohanka R, Vora M, et al
    Sofosbuvir, Peg Interferon & Ribavirin for retreatment of HCV genotype 1b following Sofosbuvir and Ledipasvir failure.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29667.
    PubMed     Text format    

  10. POORDAD F, Pol S, Asatryan A, Buti M, et al
    Glecaprevir/Pibrentasvir in Patients with HCV Genotype 1 or 4 and Prior Direct-acting Antiviral Treatment Failure.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29671.
    PubMed     Text format     Abstract available

  11. YURDAYDIN C, Keskin O, Kalkan C, Karakaya F, et al
    Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The lowr HDV - 1 study.
    Hepatology. 2017 Nov 20. doi: 10.1002/hep.29658.
    PubMed     Text format     Abstract available


    J Hepatol

  12. INNES H, Barclay ST, Hayes PC, Fraser A, et al
    The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen.
    J Hepatol. 2017 Nov 15. pii: S0168-8278(17)32429.
    PubMed     Text format     Abstract available

  13. TANG Y, Li H, Li J, Liu Y, et al
    Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil mediated complement activation.
    J Hepatol. 2017 Nov 14. pii: S0168-8278(17)32433.
    PubMed     Text format     Abstract available


    J Infect Dis

  14. WU D, Ning Q
    Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  15. LIU CJ, Kao JH
    NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction.
    J Infect Dis. 2017;216.
    PubMed     Text format    

  16. TSENG TC, Huang LR
    Immunopathogenesis of Hepatitis B Virus.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  17. SU TH, Kao JH
    Unmet Needs in Clinical and Basic Hepatitis B Virus Research.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  18. YANG HC, Shih YF, Liu CJ
    Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  19. CHAUDHURY CS, Sheehan J, Chairez C, Akoth E, et al
    No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
    J Infect Dis. 2017 Nov 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. BUTI M, Riveiro-Barciela M, Esteban R
    Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  21. ROSENBERG BR, Freije CA, Imanaka N, Chen ST, et al
    Genetic variation at IFNL4 influences extrahepatic interferon stimulated gene expression in chronic HCV patients.
    J Infect Dis. 2017 Nov 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. CHOI J, Lim YS
    Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    J Viral Hepat

  23. KEISER O, Giudici F, Mullhaupt B, Junker C, et al
    Trends in hepatitis C-related mortality in Switzerland.
    J Viral Hepat. 2017 Nov 20. doi: 10.1111/jvh.12803.
    PubMed     Text format     Abstract available

  24. BROWN A, Hezode C, Zuckerman E, Foster GR, et al
    Efficacy and safety of 12 weeks of elbasvir +/- grazoprevir +/- ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study.
    J Viral Hepat. 2017 Nov 20. doi: 10.1111/jvh.12801.
    PubMed     Text format     Abstract available


    J Virol

  25. PAUL D, Madan V, Ramirez O, Bencun M, et al
    Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles.
    J Virol. 2017 Nov 22. pii: JVI.01890-17. doi: 10.1128/JVI.01890.
    PubMed     Text format     Abstract available

  26. AGARWAL S, Baccam P, Aggarwal R, Veerapu NS, et al
    Novel Synthesis and Phenotypic Analysis of Mutant Clouds for Hepatitis E Virus Genotype 1.
    J Virol. 2017 Nov 22. pii: JVI.01932-17. doi: 10.1128/JVI.01932.
    PubMed     Text format     Abstract available

  27. SKARDASI G, Chen AY, Michalak TI
    Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.
    J Virol. 2017 Nov 22. pii: JVI.01790-17. doi: 10.1128/JVI.01790.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  28. ZELENEV A, Li J, Mazhnaya A, Basu S, et al
    Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Lancet Infect Dis. 2017 Nov 15. pii: S1473-3099(17)30676.
    PubMed     Text format     Abstract available

  29. DAHARI H, Boodram B
    How to eliminate HCV in people who inject drugs in the USA.
    Lancet Infect Dis. 2017 Nov 15. pii: S1473-3099(17)30678.
    PubMed     Text format    


    Transplantation

  30. TROTTER PB, Summers DM, Ushiro-Lumb I, Robb M, et al
    Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002033.
    PubMed     Text format     Abstract available

  31. AGARWAL N, Davis RJ, Gracey DM, Wong G, et al
    Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002034.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: